nafamostat has been researched along with Lupus Nephritis in 1 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, T | 1 |
| Fujita, Y | 1 |
| Inagi, R | 1 |
| Inoue, I | 1 |
| Sugiyama, S | 1 |
| Maeda, K | 1 |
1 other study available for nafamostat and Lupus Nephritis
| Article | Year |
|---|---|
Effectiveness of nafamostat mesilate on glomerulonephritis in immune-complex diseases.
Topics: Benzamidines; Complement Inactivator Proteins; Cryoglobulinemia; Glomerulonephritis; Guanidines; Hum | 1993 |